Search for: "BIOTECH, INC." Results 61 - 80 of 1,249
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Mar 2022, 10:39 am by Race to the Bottom
Additionally, Theranos was a medical device company operating in a highly regulated biotech space. [read post]
24 Feb 2022, 6:12 pm by Dennis Crouch
Sanofi has the potential of being a huge case in terms of how it impacts the future of biotech innovation. [read post]
1 Feb 2022, 12:32 am by Roel van Woudenberg
Regele dated 16 January 2017D50 Assignment by the inventors to Alexion Pharmaceuticals Inc. dated 28.03.2007, 02.04.2007 and 11.09.2007 respectivelyD51 Document supporting the name change from "UDEC Pharmaceuticals,Inc. to "Alexion Pharmaceuticals Inc"D52 Declaration of S. [read post]
21 Nov 2021, 10:51 am by Kevin LaCroix
Ginko Bioworks, Inc. was a privately held company that operated a platform for cell programming to enable biological production of therapeutics, food products, and chemicals. [read post]
20 Oct 2021, 3:43 am
JH Biotech, Inc., Opposition No. 91244593 (September 30, 2021) [not precedential] (Opinion by Judge George C. [read post]
16 Sep 2021, 12:57 pm by Simmons Hanly Conroy
” The New York State trial is expected to continue into October with remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
23 Aug 2021, 2:45 pm by Kevin LaCroix
  Rising Biosciences, Inc. produces and sells health-related products and services. [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
25 Jun 2021, 4:15 am by Logan Murr
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
25 Jun 2021, 4:15 am by Logan Murr
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
8 Jun 2021, 9:02 pm by Thomas Gremillion
  That’s because last week, biotech company AquaBounty Technologies Inc. announced that it is harvesting several tons of genetically modified salmon, which will soon be sold at restaurants and other “away-from-home” dining retailers around the country. [read post]
15 May 2021, 6:00 pm by Juvan Bonni
 Bashar Malkawi: Royalty Rate Determination in Patent Infringement Cases: The U.S. and China Compared (Source: SSRN) New Job Postings on Patently-O: Boston Scientific Clark+Elbing LLP Warner Norcross + Judd LLP – Patent Associate Attorney Warner Norcross + Judd LLP – Patent Agent Weaver Austin Villeneuve & Sampson LLP Murphy, Bilak & Homiller PLLC (MBH) McNeill Baur Faegre Drinker ALG Intellectual Property, LLC PTC Therapeutics Inc Miller & Martin Workman… [read post]